Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor γ

Cytokine

Volumn 18, Issue 6, 2002, Pages 320-328

  Meier, Christoph A ^a   Chicheportiche, Rachel ^a   Juge Aubry, Cristiana E ^a   Dreyer, Magali G ^a   Dayer, Jean Michel ^a  

^a University Hospitals   (Switzerland)

Author keywords

Interleukin 1 receptor antagonist; Monocytes; Prostaglandins; Thiazolidinediones; THP 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 15 DEOXY DELTA 12,14 PROSTAGLANDIN J2; 3 (8 AMINOMETHYL 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL) 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BISINDOLYLMALEIMIDE; CALCITRIOL; CALPHOSTIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHORBOL 13 ACETATE 12 MYRISTATE; PICEATANNOL; PIOGLITAZONE; PROSTAGLANDIN DERIVATIVE; PROTEIN KINASE C INHIBITOR; RETINOIC ACID; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0036037359     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.1945     Document Type: Article

References (25)

1. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
2. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
3. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
4. 4 pathway to inflammation control
5. 2 is a ligand for the adipocyte determination factor PPARgamma
6. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
7. An antidiabetic thiazolidinedione is a high affnity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma)
8. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
9. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
10. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: Implications for cardiovascular disease
11. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
12. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
13. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
14. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-delta(12,14)-prostaglandin J(2) in activated murine macrophages
15. PPARgamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells
16. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response
17. A urine inhibitor of interleukin 1 activity that blocks ligand binding
18. Interleukin-1 receptor antagonist: Role in biology
19. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes
20. IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells
21. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
22. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
23. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice
24. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: A possible role in the resolution of arthritis